Ajanta Pharma Limited
AJANTPHARM
Rang in aandelen
#3733
Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited... Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited operates as a specialized pharmaceutical enterprise. This company, along with its subsidiaries, is dedicated to the development, manufacturing, and commercialization of finished dosage forms. Its extensive product range caters to numerous therapeutic categories, such as anti-infectives (antibiotic, anti-malarial), chronic disease management (anti-diabetic, cardiology), women's health (gynecology), pediatrics, respiratory ailments, general health, dermatology, ophthalmology, and pain management. Notable products include multivitamins, antibiotics, eye drops, and cough syrups. Ajanta Pharma boasts a substantial international footprint, operating across India, Africa, other parts of Asia, the United States, and additional global markets. Furthermore, it supplies its pharmaceutical offerings to various government entities, including armed forces, public hospitals, and governmental procurement departments.
Aandeelprijs
$35.98
Marktkapitalisatie
$4.50B
Verandering (1 dag)
-1.18%
Verandering (1 jaar)
29.38%
Land
IN
Handel Ajanta Pharma Limited (AJANTPHARM)
Categorie
Healthcare
P/B-ratio voor Ajanta Pharma Limited (AJANTPHARM)
P/B-ratio op October 2026 TTM: 9.22
Volgens de meest recente financiële rapporten en aandelenkoers van Ajanta Pharma Limited is de huidige P/B-ratio (TTM) 9.22. Eind 2024 had het bedrijf een P/B-ratio van 7.90.
P/B-ratiohistoriek voor Ajanta Pharma Limited van 2005 tot 2026
P/B-ratio aan het einde van elk jaar
| Jaar | P/B-ratio | Wijzigen |
|---|---|---|
| 2026 (TTM) | 9.22 | 6.67% |
| 2025 | 8.64 | 9.39% |
| 2024 | 7.90 | 72.86% |
| 2023 | 4.57 | -4.67% |
| 2022 | 4.79 | -7.95% |
| 2021 | 5.21 | 13.54% |
| 2020 | 4.59 | 13.10% |
| 2019 | 4.06 | -32.88% |
| 2018 | 6.04 | -38.85% |
| 2017 | 9.88 | -6.58% |
| 2016 | 10.58 | -17.66% |
| 2015 | 12.85 | 117.99% |
| 2014 | 5.89 | 51.03% |
| 2013 | 3.90 | 116.82% |
| 2012 | 1.80 | 75.69% |
| 2011 | 1.02 | -10.99% |
| 2010 | 1.15 | 201.10% |
| 2009 | 0.38 | -45.26% |
| 2008 | 0.70 | -3.96% |
| 2007 | 0.73 | -8.05% |
| 2006 | 0.79 | 15.81% |
| 2005 | 0.68 | 0.00% |
P/B-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/B-ratio | Verschil in P/B-ratio | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -45.30% |
IN
|
